Entera Bio (ENTX) Cash & Equivalents (2017 - 2026)
Entera Bio's Cash & Equivalents was $11.31 million in Q2 2026, up 4.2% from $10.86 million a year earlier and up 173.4% from the prior quarter.
Powered by 
Analysis
Entera Bio (ENTX) Cash & Equivalents (2017 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at Entera Bio came in at $7.11 million, down 17.9% from FY2024.
- Cash & Equivalents has now declined for four consecutive years, with a five-year compound annual growth rate of -3.7% (FY2020 to FY2025).
- In earlier years, Cash & Equivalents was $8.66 million in FY2024 (-21.4%), $11.02 million in FY2023 (-10.5%), $12.31 million in FY2022 (-50.6%) and $24.89 million in FY2021 (+189.7%).
- The Q2 2026 figure marks the highest quarterly Cash & Equivalents since Q1 2025.
- Compared with a year earlier, Cash & Equivalents was higher in four of the last eight quarters, with an average decline of 3.8%.
- The best year-over-year quarter for Cash & Equivalents over five years was Q4 2021 (growth of 189.7%); the worst was Q1 2026 (a decline of 67.1%).
- Per Business Quant data, ENTX's Cash & Equivalents in the three quarters before Q2 2026 was $4.14 million (Q1 2026), $7.11 million (Q4 2025) and $8.57 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Entera Bio | 142.45 Mn | 111.32 Mn | - | 11.31 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.31 Mn |
| Mar 31, 2026 | 4.14 Mn |
| Dec 31, 2025 | 7.11 Mn |
| Sep 30, 2025 | 8.57 Mn |
| Jun 30, 2025 | 10.86 Mn |
| Mar 31, 2025 | 12.57 Mn |
| Dec 31, 2024 | 8.66 Mn |
| Sep 30, 2024 | 6.92 Mn |
| Jun 30, 2024 | 9.06 Mn |
| Mar 31, 2024 | 9.19 Mn |
| Dec 31, 2023 | 11.02 Mn |
| Sep 30, 2023 | 7.59 Mn |
| Jun 30, 2023 | 9.14 Mn |
| Mar 31, 2023 | 10.69 Mn |
| Dec 31, 2022 | 12.31 Mn |
| Sep 30, 2022 | 14.32 Mn |
| Jun 30, 2022 | 17.28 Mn |
| Mar 31, 2022 | 20.11 Mn |
| Dec 31, 2021 | 24.89 Mn |
| Sep 30, 2021 | 27.40 Mn |
API Access
Entera Bio Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ENTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "ENTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=ENTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();